Indefinite Delivery Contract 36C24226D0040
Award Date 3/15/26
Last Date to Order 3/14/31
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Sofie CO., doing business as IBA Molecular, was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs through Veterans Integrated Service Network 17 (VISN 17) on September 1, 2024, with a ceiling value of $2,345,668 and an ultimate completion date of September 30, 2026. The contract procures PYLARIFY (piflufolastat F-18), a positron emission tomography imaging agent used for prostate cancer detection in VA medical facilities. The contract carries no...
- Sofie CO., doing business as IBA Molecular, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 15 (VISN 15) on January 9, 2026, valued at $1,361,625.00 with an ultimate completion date of January 8, 2031. This Total Small Business set-aside contract procures radiopharmaceuticals for positron emission tomography/computed tomography (PET/CT) oncology imaging at the Kansas City VA Medical Center. The primary products include fluorodeoxyglucose F-18...
- The Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $1,009,490.10 contract, with a performance period through August 2026, is for the supply of F-18 Prostate-Specific Membrane Agent (PSMA) radiopharmaceuticals and related products to VA medical facilities. The contract includes a base year and four option years, allowing the VA to place delivery orders for specialized imaging agents like...
- Sofie CO. has been awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide radioactive PET tracer isotopes. The single award contract has a potential value of $1,698,000 and period of performance through February 2029. Under the contract, Sofie CO. has received a $339,600 firm fixed price delivery order to supply radioactive PET tracer isotopes for use at the Veterans Affairs Medical Center...
- Sofie Co. was awarded an indefinite delivery contract from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to provide radiopharmaceuticals. The contract has a potential value of $209,760 and period of performance through July 2022. Sofie was issued two firm fixed price delivery orders against the VHA Pharmaceutical Prime Vendor contract totaling $537,032.67 to supply Pylarify Piflufolastat F18 for use in positron emission tomography...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA-VHA) awarded a single-award, indefinite delivery contract to Sofie CO., doing business as Sofie, to provide PET radiopharmaceuticals. The contract includes a base period from April 15, 2022 to April 14, 2025 with a potential value of $676,598.52. Two firm fixed price delivery orders were also awarded against the contract to provide PET radiopharmaceuticals to the VA Western New York...
- The Department of Veterans Affairs Veterans Integrated Service Network 10 (VA VISN 10) awarded a single-award indefinite delivery contract to Sofie CO., a subsidiary of Sofie Biosciences, to provide radiopharmaceutical PET imaging products and services. The $1.3 million contract, with a period of performance from October 2021 through September 2026, supports the VA's diagnostics and cancer treatment programs for veterans across the VISN 10 region. The contract requires Sofie to deliver...
- This federal contract IDV, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2, is for the supply of PET radiopharmaceuticals to the Buffalo VA Medical Center. The $1.9 million single-award IDV was granted to Sofie CO., a for-profit subsidiary of Sofie Biosciences, Inc. that specializes in radiopharmaceuticals and PET imaging agents. The initial $635,896.40 delivery order under this IDV covers the supply of five specific radiopharmaceuticals: FDG, Cu64...
- The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Sofie CO., doing business as Sofie and subsidiary of Sofie Biosciences, Inc., to provide radiopharmaceutical products and services in support of nuclear medicine diagnostic services for veterans. The single award contract, valued at up to $500,000, has a period of performance from October 1, 2022 through March 31, 2024. Two calls have been issued against the blanket purchase agreement. The...
- The key products and services being delivered under this federal contract IDV award are specialized radiopharmaceuticals and related services for medical imaging and cancer treatment. The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals. The contract IDV, valued at $5,864,170, was awarded by the Department of Veterans Affairs (VA) Veterans Integrated...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24226D0040-36C24226N0388 | Sofie CO. | $830.8k | 3/15/26 | 3/14/27 | 3/4/26 |